RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Epigenetic multidrug approach to modulate the immuno-phenotype of malignant neuroblastoma
2008-01-01 Lettini, Aa; Anzalone, L; Guidoboni, M; Calabro, L; Cortini, E; Falisi, E; Semplici, F; Fonsatti, E; Maio, M
Evaluation of the efects of systemic corticosteroid for the treatment of immune-related adverse events (irAEs) on the development oe maintenance of ipilimumab clinical activity
2009-01-01 Amin, A; Depril, V; Hamid, O; Wolchock, J; Maio, M; Neyns, B; Chin, K; Ibrahim, R; Hoos, A; O'Day, S
Expression of endoglin/CD105 on acute leukemia blast cells: Application for minimal residual disease (MRD) detection
1996-01-01 Lopardo, C; Altomonte, M; Boccuni, P; Dinoto, R; Vacca, C; Maio, M; Delvecchio, L
Five-year survival rates for patients (pts) with metastatic melanoma (mm) treated with ipilimumab (ipi) in phase II trials
2012-01-01 Lebbe, C; Weber, Js; Maio, M; Neyns, B; Harmankaya, K; Chin, K; Mcdowell, Do; Cykowski, L; Mchenry, Mb; Wolchok, Jd
Five-Year survival Rates for patients (PTS) with metatastatic melanoma(MM) treated with ipilimumab (IPI) in phase II trials
2012-01-01 Lebbe, C; Weber, J; Maio, M; Neyns, B; Harmankaya, K; Chin, K; Mcdowell, D; Cykowski, L; Mchenry, B; Wolchok, J
Four-year survival update for metastatic melanoma patients treated with IPILIMUMAB plus plus DACARBAZINE on phase 3 study CA184-024
2012-01-01 Maio, M; Bondarenko, I; Robert, C; Thomas, L; Garbe, C; Testori, A; Francis, S; Chin, K; Wolchok, J
Four-year survival update for metastatic melanoma patients treated with IPILIMUMAB plus DACARBAZINE on phase 3 study CA184-024
2012-01-01 Maio, M; Bondarenko, I; Robert, C; Thomas, L; Garbe, C; Testori, A; Francis, S; Chin, K; Wolchok, J
Health-Care resource Utilization in advanced melanoma: an analysis from the MELODY observational study
2010-01-01 Lorigan, P; Maio, M; Middleton, M; Testori, A; Bedane, C; van Baardewijk, M; Konto, C; Dueymes, A; Lebbe, C
Immunization with recombinant Mage-A3 protein combined with adjuvant system AS15 or AS02B in patients with unresectable and progressive metastatic cutaneous melanoma: a randomized open -label phase II study of the EORTC Melanoma Group (16032-18031)
2008-01-01 Kruit, Wh; Suciu, S; Dreno, B; Chiarion-Sileni, V; Mortier, L; Robert, C; Maio, M; Brichard, Vg; Lehmann, F; Keilholz, U
Immunobiologic Activity of the Demethylating Dinucleotide SGI-110
2010-01-01 Coral, S; Sigalotti, L; Fonsatti, E; Parisi, G; Colizzi, F; Nicolay, Hj; Taverna, P; Maio, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 67
- 1 Contributo su Rivista::1.5 Abstract in rivista 67
Data di pubblicazione
- 2010 - 2020 28
- 2000 - 2009 31
- 1995 - 1999 8
Rivista
- ANNALS OF ONCOLOGY 15
- JOURNAL OF CLINICAL ONCOLOGY 11
- EUROPEAN JOURNAL OF CANCER 7
- EUROPEAN JOURNAL OF CANCER. SUPPLEMENT 7
- JOURNAL OF IMMUNOTHERAPY 5
- CELLULAR ONCOLOGY 3
- HUMAN IMMUNOLOGY 3
- JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 3
- ASIA PACIFIC JOURNAL OF CLINICAL ONCOLOGY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
Keyword
- ipilimumab 3
- melanoma 2
- brain metastases 1
- fotemustine 1
- guadecitabina 1
- guadecitabine 1
- nivolumab 1
Lingua
- eng 41
Accesso al fulltext
- no fulltext 60
- reserved 4
- open 3
Appartenenza
- Dipartimento di Biotecnologie Mediche 4
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze 67